5 Nov 2015 16:15
AMENDMENT(Section 2a and 2b)
Β
Β FORM 38.5(a)
Β
IRISHΒ TAKEOVERΒ PANEL
Β
DISCLOSUREΒ UNDERΒ RULEΒ 38.5(a)Β OFΒ THEΒ IRISHΒ TAKEOVERΒ PANELΒ ACT,Β 1997, TAKEOVER Β RULES,Β 2013
Β
DEALINGS BY CONNECTEDΒ EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARYΒ STATUS AND DEALING IN A CLIENT-SERVING CAPACITY
Β
Β
1. KEYΒ INFORMATION
Β Name of exempt market-maker | Morgan Stanley & Co. International plc |
Β Company dealt in | PFIZER INC |
Β Class of relevant security to which the dealings being disclosed relate (Note 1) | US$0.05 COMMON STOCK |
Β Date of dealing | 03 NOVEMBER 2015 |
Β
Β
2. DEALINGSΒ (NoteΒ 2)
Β
(a) PurchasesΒ andΒ sales
Β Total number of relevant secuities accquired | Β Highest price paid (Note 3) | Β Lowest price paid (Note 3) |
Β Β 108,081 | Β 35.0000 USD | Β 34.7166 USD |
Β
Β Total number of relevant secuities disposed | Β Highest price paid (Note 3) | Β Lowest price paid (Note 3) |
Β Β 108,081 | Β 35.0000 USD | Β 34.7166 USD |
Β
Β
(b) DerivativesΒ transactionsΒ (otherΒ thanΒ optionsΒ transactions)
Β
Β Product name, e.g. CFD | Β Nature of transaction (Note 4) | Β Number of relevant securities (Note 5) | Β Price per unit |
Β CFD | Β LONG | Β 7,285 | Β 34.6900 USD |
Β CFD | Β LONG | Β 1,200 | Β 34.6958 USD |
Β CFD | Β LONG | Β 1,300 | Β 34.7100 USD |
Β CFD | Β LONG | Β 358 | Β 34.9227 USD |
Β CFD | Β LONG | Β 498 | Β 34.9419 USD |
Β CFD | Β SHORT | Β 7,285 | Β 34.6900 USD |
Β CFD | Β SHORT | Β 973 | Β 34.6975 USD |
Β CFD | Β SHORT | Β 1,141 | Β 34.7163 USD |
Β CFD | Β SHORT | Β 240 | Β 34.8200 USD |
Β CFD | Β SHORT | Β 774 | Β 34.8271 USD |
Β CFD | Β SHORT | Β 392 | Β 34.8500 USD |
Β CFD | Β SHORT | Β 1,000 | Β 34.8875 USD |
Β CFD | Β SHORT | Β 1,000 | Β 34.9400 USD |
Β CFD | Β SHORT | Β 400 | Β 34.9400 USD |
Β CFD | Β SHORT | Β 200 | Β 34.9400 USD |
Β CFD | Β SHORT | Β 200 | Β 34.9550 USD |
Β CFD | Β SHORT | Β 352 | Β 34.9700 USD |
Β CFD | Β SHORT | Β 3,436 | Β 34.9769 USD |
Β
Β
(c) OptionsΒ transactionsΒ inΒ respectΒ ofΒ existingΒ relevantΒ securities
Β
i) Writing,Β selling,Β purchasingΒ orΒ varying
Β
Β Product name, eg call option | Β Writing, selling, purchasing, varying etc | Β Number of securities to which the option relates (Note 5) | Β Exercise Price | Β Type, e.g American, European etc | Β Expiry Date | Β Option money paid/received per unit (Note 3) |
Β N/A | Β N/A | Β N/A | Β N/A | Β N/A | Β N/A | Β N/A |
Β
(ii) Exercising
Β
Β Product name, eg call option | Β Number of securities | Β Exercise price per unit (Note 3) |
Β N/A | Β N/A | Β N/A |
Β
Β
3. OTHER INFORMATION
Β
Agreements, arrangements or understandings relating to options or derivatives
Β
Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. Β |
Β Β Β Β Β |
Β
Β
Β Date of disclosure | 05 NOVEMBER 2015 |
Β Contact Name | Craig Horsley |
Β Telephone Number | +44(141) 245 7736 |
Β Name of offeree/offeror with which connected | ALLERGAN PLC |
Nature of connection (Note 6) | Advisory |
Β
Follow the stocks